Cathay Biotech Inc. (SHA:688065)
China
· Delayed Price · Currency is CNY 47.90
+0.57 (1.20%)
Feb 21, 2025, 3:00 PM CST
Cathay Biotech Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 20, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Market Capitalization | 27,845 | 32,012 | 35,749 | 76,786 | 35,439 | - | Upgrade
|
| Market Cap Growth | -14.51% | -10.45% | -53.44% | 116.67% | - | - | Upgrade
|
| Enterprise Value | 28,108 | 31,823 | 33,878 | 71,142 | 29,114 | - | Upgrade
|
| Last Close Price | 47.90 | 54.72 | 60.82 | 130.07 | 59.57 | - | Upgrade
|
| PE Ratio | 70.39 | 87.34 | 64.61 | 129.11 | 77.43 | - | Upgrade
|
| Forward PE | - | 46.74 | 38.31 | 89.61 | 56.23 | - | Upgrade
|
| PS Ratio | 10.13 | 15.14 | 14.64 | 32.49 | 23.67 | - | Upgrade
|
| PB Ratio | 2.43 | 2.17 | 2.38 | 5.23 | 3.09 | - | Upgrade
|
| P/TBV Ratio | 2.58 | 3.06 | 3.51 | 7.77 | 3.49 | - | Upgrade
|
| P/OCF Ratio | 38.64 | 56.22 | 44.48 | 132.69 | 68.82 | - | Upgrade
|
| EV/Sales Ratio | 10.17 | 15.05 | 13.88 | 30.10 | 19.45 | - | Upgrade
|
| EV/EBITDA Ratio | 46.69 | 71.27 | 50.43 | 106.53 | 51.48 | - | Upgrade
|
| EV/EBIT Ratio | 90.92 | 192.23 | 83.32 | 142.50 | 65.10 | - | Upgrade
|
| Debt / Equity Ratio | 0.09 | 0.12 | 0.07 | 0.05 | - | 0.06 | Upgrade
|
| Debt / EBITDA Ratio | 2.13 | 3.98 | 1.68 | 1.11 | - | 0.46 | Upgrade
|
| Asset Turnover | 0.15 | 0.12 | 0.14 | 0.17 | 0.17 | 0.35 | Upgrade
|
| Inventory Turnover | 1.38 | 1.01 | 1.17 | 1.56 | 1.01 | 1.55 | Upgrade
|
| Quick Ratio | 2.16 | 1.70 | 4.75 | 8.14 | 16.89 | 1.42 | Upgrade
|
| Current Ratio | 2.87 | 2.22 | 5.95 | 9.36 | 19.42 | 2.60 | Upgrade
|
| Return on Equity (ROE) | 2.60% | 2.74% | 4.12% | 4.84% | 5.67% | 12.28% | Upgrade
|
| Return on Assets (ROA) | 1.06% | 0.56% | 1.49% | 2.20% | 3.09% | 6.13% | Upgrade
|
| Return on Capital (ROIC) | 1.19% | 0.63% | 1.61% | 2.32% | 3.40% | 8.07% | Upgrade
|
| Return on Capital Employed (ROCE) | 1.98% | 1.07% | 2.48% | 3.34% | 3.82% | 10.74% | Upgrade
|
| Earnings Yield | 1.43% | 1.14% | 1.55% | 0.77% | 1.29% | - | Upgrade
|
| FCF Yield | -0.57% | -3.12% | -9.50% | -1.15% | -0.70% | - | Upgrade
|
| Dividend Yield | 0.40% | 0.35% | 0.30% | 0.25% | 0.96% | - | Upgrade
|
| Payout Ratio | 35.32% | 37.58% | 37.39% | 57.11% | 0.85% | 25.34% | Upgrade
|
| Buyback Yield / Dilution | -0.97% | 0.10% | 0.12% | -7.38% | -6.91% | -1.57% | Upgrade
|
| Total Shareholder Return | -0.57% | 0.45% | 0.41% | -7.14% | -5.95% | -1.57% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.